Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 6/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.43 |
| ▸ | HTR1A | P08908 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.43 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.43 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.43 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.43 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL339065 | 0.83 | CHRM5 (0.44) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL28176595 | 0.81 | CHRM5 (0.43) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL28031252 | 0.77 | CHRM5 (0.42) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL28302064 | 0.76 | CA2 (0.33) | LMNATSHR | |
| SCHEMBL29199666 | 0.76 | CHRM5 (0.39) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL15527811 | 0.75 | TSHR (0.55) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL38654756 | 0.74 | CHRM5 (0.41) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL339063 | 0.73 | RECQL (0.45) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Sulfuric Acid SCHEMBL3968595 | 0.73 | CHRM5 (0.44) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL3788005 | 0.73 | CA1 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150174160-A1 | METHODS FOR TREATING, DIAGNOSING AND/OR MONITORING PROGRESSION OF OXO ASSOCIATED STATES | PRAVDA JAY (US) | 2015-06-25 | — | — | US | claimed |
| EP-2866565-A2 | METHODS FOR TREATING, DIAGNOSING AND/OR MONITORING PROGRESSION OF OXO ASSOCIATED STATES | Pravda, Jay (US) | 2015-05-06 | — | — | EP | claimed |
| CN-104582490-A | Methods of treating, diagnosing and/or monitoring the progression of oxygen-related diseases | PRAVDA JAY | 2015-04-29 | — | — | CN | claimed |
| US-20140335205-A1 | MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | THERAPEUTIC RES LLC (US) | 2014-11-13 | — | — | US | claimed |
| WO-2014008273-A2 | METHODS FOR TREATING, DIAGNOSING AND/OR MONITORING PROGRESSION OF OXO ASSOCIATED STATES | PRAVDA JAY (US) | 2014-01-09 | — | — | WO | claimed |
| US-20120322773-A1 | MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | PRAVDA JAY (US) | 2012-12-20 | — | — | US | claimed |
| US-20100112088-A1 | MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | PRAVDA JAY | 2010-05-06 | — | — | US | claimed |
| US-10064877-B2 | Materials and methods for treatment and diagnosis of disorders associated with oxidative stress | THERAPEUTIC RESEARCH, LLC (US) | 2018-09-04 | — | — | US | disclosed |
| US-20170296559-A1 | MATERIALS AND METHODS FOR TREATMENT AND DIAGNOSIS OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | THERAPEUTIC RES LLC (US) | 2017-10-19 | — | — | US | disclosed |
| US-20170182067-A1 | MATERIALS AND METHODS FOR TREATMENT AND DIAGNOSIS OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | THERAPEUTIC RES LLC (US) | 2017-06-29 | — | — | US | disclosed |
| US-9511049-B2 | Materials and methods for treatment and diagnosis of disorders associated with oxidative stress | THERAPEUTIC RESEARCH LLC (US) | 2016-12-06 | — | — | US | disclosed |
| US-20150174160-A1 | METHODS FOR TREATING, DIAGNOSING AND/OR MONITORING PROGRESSION OF OXO ASSOCIATED STATES | PRAVDA JAY (US) | 2015-06-25 | — | — | US | disclosed |
| EP-2866565-A2 | METHODS FOR TREATING, DIAGNOSING AND/OR MONITORING PROGRESSION OF OXO ASSOCIATED STATES | Pravda, Jay (US) | 2015-05-06 | — | — | EP | disclosed |
| EP-2162125-B1 | Composition for rectal administration combined with an oral alpha-lipoic acid composition for the treatment of inflammatory bowel disease | PRAVDA JAY (US) | 2011-10-19 | — | — | EP | disclosed |
| US-20100184728-A1 | MATERIALS AND METHODS FOR TREATMENT AND DIAGNOSIS OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | THERAPEUTIC RESEARCH LLC (US) | 2010-07-22 | — | — | US | disclosed |
| CN-101707877-A | Materials and methods for diagnosis and treatment of oxidative stress disorders | JAY PRAVDA | 2010-05-12 | — | — | CN | disclosed |
| US-20100112088-A1 | MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | PRAVDA JAY | 2010-05-06 | — | — | US | disclosed |
| EP-2162125-A2 | MATERIALS AND METHODS FOR TREATMENT AND DIAGNOSIS OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | Pravda, Jay (US) | 2010-03-17 | — | — | EP | disclosed |
| WO-2008156671-A2 | MATERIALS AND METHODS FOR TREATMENT AND DIAGNOSIS OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | PRAVDA JAY (US) | 2008-12-24 | — | — | WO | disclosed |
| US-7312243-B1 | Materials and methods for treatment of gastrointestinal disorders | THERAPEUTIC RESEARCH, LLC | 2007-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10064877-B2 | Materials and methods for treatment and diagnosis of disorders associated with oxidative stress | NR3C1, GSTA1, LTC4S | CHRM5 821/4885CHRM1 1225/4885CHRM3 2376/4885 |
| US-20100184728-A1 | MATERIALS AND METHODS FOR TREATMENT AND DIAGNOSIS OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | NR3C1, GSTA1, LTC4S | CHRM5 821/4885CHRM1 1225/4885CHRM3 2376/4885 |
| US-20120322773-A1 | MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | LPO, ALOX15B, ALOX15 | CHRM5 2393/4885CHRM1 2700/4885CHRM3 3139/4885 |
| US-20170296559-A1 | MATERIALS AND METHODS FOR TREATMENT AND DIAGNOSIS OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | NR3C1, GSTA1, LTC4S | CHRM5 821/4885CHRM1 1225/4885CHRM3 2376/4885 |
| US-20140335205-A1 | MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | TXN, GPX4, TXN2 | CHRM5 3296/4885CHRM1 4194/4885CHRM3 3493/4885 |
| US-20100112088-A1 | MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | TXN, GPX4, TXN2 | CHRM5 3296/4885CHRM1 4194/4885CHRM3 3493/4885 |
| US-20150174160-A1 | METHODS FOR TREATING, DIAGNOSING AND/OR MONITORING PROGRESSION OF OXO ASSOCIATED STATES | OAT, OTC, HOGA1 | CHRM5 3847/4885CHRM1 3405/4885CHRM3 2911/4885 |
| US-20170182067-A1 | MATERIALS AND METHODS FOR TREATMENT AND DIAGNOSIS OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | NR3C1, GSTA1, LTC4S | CHRM5 821/4885CHRM1 1225/4885CHRM3 2376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.